AmerisourceBergen

Drug Retailers
ABC
$ 137 (2)%
Share price
$ 28 bn
Market Cap
$ 33 bn
Enterprise Value

Carbon footprint

6.5 Ton
GHG emissions per $ 1 mln investment
0.16x the weighted average for S&P 500
FY2021
How is this calculated?
+99%
YOY change in GHG emissions
Stronger than the +4.9% weighted average for S&P 500
FY2021 vs. previous year

Primary Climate Goal

-0.4%
Proj. YOY change in GHG emissions (Scope 1 + 2)
Weaker than the -6.6% weighted average for S&P 500
FY2022
How is this calculated?

AmerisourceBergen aims to reduce Scope 1 + 2 by 5% by 2022 from a base year 2019

This target is most likely outdated and the company appears to have already achieved it
This target has not been verified as science based according to SBTi
AmerisourceBergen's actual and proj. GHG emissions (Scope 1 + 2) (Kt of CO2e)

GHG emissions and Carbon intensity

AmerisourceBergen's GHG emissions (market-based) (Kt of CO2e)
AmerisourceBergen's Carbon intensity (Tons per 1 USDm)

AmerisourceBergen's carbon footprint

AmerisourceBergen reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 30 September 2021 at 215 Kt (+107/+99% y-o-y). Carbon intensity also was up at 1 t (+0.4/+67% y-o-y).

AmerisourceBergen's Scope 3 emissions increased to 45 Kt (+19/+75% y-o-y). The parameter has been fairly volatile.

The company is committed to reducing Scope 1 + 2 by 5% by 2022 from a base year 2019, which it appears to have already achieved as of 2021. This target, however, has not been recognised as science-based (and as aligned with Paris Agreement) by the SBTi.

Company environmental metrics

Show more...